Correlation of statin therapy and severity of diabetic retinopathy at a tertiary care hospital in Northern India: a randomised control trial

Authors

  • Neha Chhabra Department of Ophthalmology, Government Medical Patiala, Punjab, India
  • Rohit Raina Department of General Medicine, All India Institute of Medical Sciences, Bathinda, Punjab, India

DOI:

https://doi.org/10.18203/2349-3259.ijct20250128

Keywords:

Diabetes, Diabetic retinopathy, Statins

Abstract

Background: Aim was to study the correlation between statin therapy and the severity of diabetic retinopathy.

Methods: A randomised control trial was performed at a tertiary care hospital in northern India. The severity of diabetic retinopathy was compared between statin and non-statin users from the fundus examination and medical records of patients presenting to the Outpatient department from July 2022 to May 2023. A total of 100 patients with diabetic retinopathy were enrolled in the study, all meeting the inclusion criteria. The patients were divided into statin users and nonusers. The results were analysed to compare the severity of DR between the two groups.

Results: Out of 45 statin users, 28 (62.2%) had mild non-proliferative diabetic retinopathy (NPDR), 10 (22.2%) had a moderate grade of NPDR, 5 (11.1%) had severe NPDR, 1 (2.22%) had PDR and 1 (2.22%) patient had diabetic macular edema (DME). Out of 55 non-statin users, 10 (18.18%) had mild diabetic NPDR, 16 (29.09%) had a moderate grade of NPDR, 16 (29.09%) had severe NPDR, 8(14.54%) had PDR and 4 (7.27%) patients had DME and 1 (1.81%) patient presented with both DME and vitreous haemorrhage (VH).

Conclusions: In type 2 diabetic patients, patients on statins had significantly lower grades of retinopathy as compared to those who were not taking statins. Thus, statins can be given prophylactically to lower the severity of diabetic retinopathy.

Metrics

Metrics Loading ...

References

Prevention of Blindness from Diabetes Mellitus: Report of a WHO Consultation in Geneva, Switzerland, 9-11 November 2005. World Health Organization: Geneva. 2006.

Antonetti DA, Klein R, Gardner TW. Diabetic retinopathy. N Eng J Med. 2012;366(13):1227-39. DOI: https://doi.org/10.1056/NEJMra1005073

Reddy SV, Husain D. Panretinal photocoagulation: A review of complications. Seminars Ophthalmol. 2018;33(1):83-8. DOI: https://doi.org/10.1080/08820538.2017.1353820

Kang EYC, Chen TH, Garg SJ, Sun CC, Kang JH, Wu WC, et al. Association of statin therapy with prevention of vision-threatening diabetic retinopathy. JAMA Ophthalmol. 2019;137(4):363-71.

Heart Protection Study Collaborative Group Heart. Protection Study Collaborative GMRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial. Lancet. 2002;360:7-22. DOI: https://doi.org/10.1016/S0140-6736(02)09327-3

Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HAW, Livingstone SJ, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative atorvastatin Diabetes Study (CARDS): A multicentre randomised placebo-controlled trial. Lancet. 2004;364(9435):685-96. DOI: https://doi.org/10.1016/S0140-6736(04)16895-5

Patel KK, Sehgal VS, Kashfi K. Molecular targets of statins and their potential side effects: Not all the glitter is gold. Eur J Pharmacol. 2022;922:174906. DOI: https://doi.org/10.1016/j.ejphar.2022.174906

Julius A, Hopper W. A non-invasive, multi-target approach to treat diabetic retinopathy. Biomed Pharmacotherapy. 2019;109:708-15. DOI: https://doi.org/10.1016/j.biopha.2018.10.185

Klein BE, Moss SE, Klein R, Surawicz TS. The Wisconsin epidemiologic study of diabetic retinopathy. XIII. Relationship of serum cholesterol to retinopathy and hard exudate. Ophthalmol. 1991;98(8):1261-5. DOI: https://doi.org/10.1016/S0161-6420(91)32145-6

Vail D, Callaway NF, Ludwig CA, Saroj N, Moshfeghi DM. Lipid-lowering medications are associated with lower risk of retinopathy and ophthalmic interventions among United States patients with diabetes. Am J Ophthalmol. 2019;207:378-84. DOI: https://doi.org/10.1016/j.ajo.2019.05.029

Hermans MP, Fruchart JC. Reducing vascular events risk in patients with dyslipidaemia: An update for clinicians. Therap Adv Chronic Dis. 2011;2(5):307-23. DOI: https://doi.org/10.1177/2040622311413952

Gupta A, Gupta V, Thapar S, Bhansali A. Lipid-lowering drug atorvastatin as an adjunct in the management of diabetic macular edema. Am J Ophthalmol. 2004;137(4):675-82. DOI: https://doi.org/10.1016/j.ajo.2003.11.017

Priyadarshini P, Chogtu B, Bhandary SV, Kabirdev, Magazine R. Association of use of statins with progression of diabetic retinopathy at a tertiary Care Hospital in Southern India. J Current Ophthalmol. 2022;34(2):234-40. DOI: https://doi.org/10.4103/joco.joco_70_21

Das R, Kerr R, Chakravarthy U, Hogg RE. Dyslipidemia and diabetic macular edema: A systematic review and meta-analysis. Ophthalmology. 2015;122(9):1820-7. DOI: https://doi.org/10.1016/j.ophtha.2015.05.011

Kang EYC, Chen TH, Garg SJ, Sun CC, Kang JH, Wu WC, et al. Association of statin therapy with prevention of vision-threatening diabetic retinopathy. JAMA Ophthalmol. 2019;137(4):363-71. DOI: https://doi.org/10.1001/jamaophthalmol.2018.6399

Keech AC, Mitchell P, Summanen PA, O’Day J, Davis TM, Moffitt MS, et al. Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): A randomised controlled trial. Lancet. 2007;370(9600):1687-97. DOI: https://doi.org/10.1016/S0140-6736(07)61607-9

Bloomgarden ZT. Diabetic retinopathy and diabetic neuropathy. Diabetes Care. 2007;30(3):760-5. DOI: https://doi.org/10.2337/dc07-zb03

Sen K, Misra A, Kumar A, Pandey RM. Simvastatin retards progression of retinopathy in diabetic patients with hypercholesterolemia. Diabetes Res Clin Pract. 2002;56(1):1-11. DOI: https://doi.org/10.1016/S0168-8227(01)00341-2

Downloads

Published

2025-01-28

How to Cite

Chhabra, N., & Raina, R. (2025). Correlation of statin therapy and severity of diabetic retinopathy at a tertiary care hospital in Northern India: a randomised control trial. International Journal of Clinical Trials, 12(1), 1–6. https://doi.org/10.18203/2349-3259.ijct20250128

Issue

Section

Original Research Articles